Complexa Inc. is a company based out of 1055 Westlakes Dr, Berwyn, Pennsylvania, United States.
Location: United States, Pennsylvania, Easttown Township
Employees: 1-10
Total raised: $75.2M
Founded date: 2008
Investors 5
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | Innovation... | innovation... |
| - | Technology... | pivotcente... |
| - | Andera Par... | anderapart... |
| - | Riverfront... | riverfront... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 26.07.2017 | Series C | $62M | New Enterp... |
| 04.06.2014 | Series B | $13M | - |
| 11.10.2013 | - | $200K | - |
Mentions in press and media 16
| Date | Title | Description |
| 27.07.2017 | Intellipharmaceutics shares crushed as FDA experts snub pain drug; Moncef Slaoui joins Moderna board | → After getting chastised by regulators in an internal FDA review of Toronto-based Intellipharmaceutics‘ $IPCI new pain drug Rexista, a panel of outside experts joined in, voting to recommend a rejection of the ther... |
| 27.07.2017 | Term Sheet — Thursday, July 27 | THREE THINGS Good morning, Term Sheet readers. This is Polina Marinova again, filling in for Erin. Send your feedback to polina.marinova@fortune.com, or find me on Twitter @polina_marinova. Paid Content You can't secure what you can't see F... |
| 26.07.2017 | Complexa Completes $62M Series C Funding | Complexa Inc., a Radnor, Pa.-based clinical stage biopharmaceutical company, completed a $62m Series C funding. The round was led by New Enterprise Associates (NEA) and Pfizer Venture Investments, with participation from Edmond de Rothschil... |
| 26.07.2017 | Complexa Raises $62 Million Series C | Complexa Inc., a clinical stage biopharmaceutical company, today announced the completion of a $62 million Series C funding round led by New Enterprise Associates (NEA) and Pfizer Venture Investments, LLC. Participation in this round also i... |
| 26.07.2017 | NEA Leads $62M Series C for Complexa | Complexa Inc., a clinical stage biopharmaceutical company, today announced the completion of a $62 million Series C funding round led by New Enterprise Associates (NEA) and Pfizer Venture Investments, LLC. Participation in this round also i... |
| 26.07.2017 | Complexa Raises $62M in Series C | RADNOR, PA, Clinical stage biopharmaceutical company, today announced the completion of a $62 million Series C funding round led by New Enterprise Associates. >> Click here for more funding data on Complexa >> To export Comp... |
| 04.06.2014 | Complexa Completes $13M Series B Financing | Complexa, Inc., a Pittsburgh, PA-based clinical-stage platform anti-inflammatory and fibrotic disease-focused biopharmaceutical company, completed a $13m Series B financing. The round was led by JAFCO Life Science Investment, a part of JAFC... |
| 04.06.2014 | Drug developer with kidney disease treatment raises $13M ahead of IND filing | JAFCO Life Science Investment led the Series B round and current investors also took part. Among its investors are Scientific Health Development, Wistar Morris Foundation and UpStart. Its drug, CXA-10, will be used in an IV form to treat ac... |
| 11.10.2013 | Complexa Raises $200K in Funding | Complexa, Inc., a Pittsburgh, PA-based biopharmaceutical company focused on treating inflammatory and metabolic disorders with nitrated unsaturated fatty acids, raised $200k in funding. Pittsburgh Life Sciences Greenhouse (PLSG), managing m... |
| 16.04.2013 | Kidney drug that uses fatty acid derivatives anticipates first in-human trials this summer | Its drug will first be applied to treat acute kidney injury that occurs from inflammatory reaction to dye injections used with certain types of medical imaging, such as coronary angiography. Called contrast-induced nephropathy, this complic... |
Show more